with BioCreative Strategies
For Axolotl Biosciences
Your commercial system, built on your market and in your nameDraft · to sign
You make bioinks for human tissue models. This page shows how we'd find the labs and teams who need them, and the system we'd build with you to reach them. It grows each time we talk.
What we heard
Your goals, how labs find TissuePrint today, who chooses the ink, and what we'll send next, in your words. Lands here once our notes from the first call are written up.
How we'd help
See your whole market
Every lab, core and pharma group printing tissue models, in one database, with the papers, grants and news that say who's moving.
Reach the right people
One message per scientist, written from your words and their latest work, on email and LinkedIn. You approve every one.
Own all of it
Your server, your database, your code and your knowledge base, set up in your name from the first day. Your team builds along.
What's next
A second call to walk this page together and pick where to start.
The Foundation
Everything else is built on this
Every engagement starts with the Foundation: your context and your data first, then the skills, tools, agents and screens that put them to work. Pick a layer to see what it holds for Axolotl.
Context: what the system knows about Axolotl
- Your products: TissuePrint, a fibrin-based bioink in two formulations, for hiPSCs, neural progenitors and mesenchymal stem cells.
- Your words: xeno-free · designed for use with fragile cells · high cell viability post printing · compatible with multiple bioprinters · structures that remain in culture for over a month.
- Who buys: the neuroscience PI, the core facility manager, the in vitro biology lead at pharma or a CRO, lab purchasing.
- Your brand: your blue and coral, Montserrat, your logo, read from your site, so everything we make looks like you.
From axolotlbiosciences.com, read 2026-11-08; refined with your team in the first round
Data: two kinds, landed in one database
Unstructured
News, sites and documents, read through feeds and keywords we set for your market.
Structured
The life sciences sources, read by API, and your own records.
Your records: orders from your web shop and any CRM, brought in by CSV or API, or built from scratch if you don't have one yet.
Skills and tools, out of the box
Work written out step by step, and the software it calls: find a lab, verify a person, read a methods section, score an account, write a message, make a post. They come from a library we've built and tested many times, and we add yours as we go.
Agents and the screens your team uses
Agents run those skills inside limits a person sets: one classifies and enriches the labs, one watches for buying moments, one drafts the messages. Your app shows the targets, the signals and every account, and nothing goes out without a person.
The operating system
All of it run as one, toward your goals, on your server and in your name. Each new language model makes it stronger without a rebuild.
Your market, already mapped
From our database, read 2026-11-06. A starting point: our web automation and agents build this out.
| Segment | Organizations | People | The people, by role |
|---|---|---|---|
| Academic labs | 44 | 117 | lab purchasing · neuroscience · core managers · bioprinting |
| Pharma and CRO human-model groups | 121 | 149 | in vitro biology · R&D leaders · neuroscience |
| Printer makers and distributors | 20 | 53 | leadership · sales · application scientists |
| Core facilities with bioprinters | next, found by our web automation from university core pages | ||
Outbound
One message per person, built on the Foundation
Each person's context, the channel's rules and your words go through the messaging matrix, so every message makes one point to one person. A person approves each one. Email and LinkedIn run from one place, and replies come back to the account.
Who we'd reach first
Academic labs
Neuroscience PI
A university lab printing neural tissue from stem cells. Moment: a new grant, or a methods section using fibrin.
Core facilities
Core facility manager
A shared bioprinter, many labs, many inks. Moment: a new printer or a new core service.
Pharma and CROs
In vitro biology lead
Building human tissue models for screening. Moment: a new program on animal-free testing.
Roles and kinds of institution only on this page; the named people stay in your app.
A three-email sequence, for the neuroscience PIDraft · to sign
Most hiPSC work still happens in 2D, and the brain isn't flat. Your lab's recent work printing neural progenitors caught our eye.
TissuePrint is a fibrin-based, xeno-free bioink designed for use with fragile cells, and it keeps printed structures in culture for over a month. Would a protocol for neural progenitors help?
In published work by Axolotl's founders, printed neural cells held high viability after printing and the tissue was cultured for 30 days. Happy to send the paper and the TissuePrint manual for your printer.
If your lab is moving from animal models to printed human tissue, the matrix is usually where it breaks. Worth a short call to see if TissuePrint fits your workflow?
Written from your site's own words; drafts for your review
The LinkedIn flow
A short note with the reason: their work on printed neural tissue. About ten requests a day, well inside LinkedIn's limits.
"Thanks for connecting. TissuePrint is fibrin-based and xeno-free, made for fragile cells. Worth sending a protocol?"
One new point: the founders' published neural tissue work, and the offer of the paper.
People you already know get their own first message, from your profile.
Marketing
Every channel, on the same foundation
Your brand, your claims and your market are already in the system, so your own Studio can make content for every channel: the website, video, social, newsletters and events.
Your brand bible, already in the system
The look
Montserrat for every word, your logo in ink and in white, imagery rules for the lab bench and printed tissue.
What we may say
Sixteen claims from your own site, each with its source and the date we read it: fibrin-based, xeno-free, designed for use with fragile cells, compatible with multiple bioprinters, and more.
Never said: prices, product names you haven't published, other companies' names in a piece.
Captured from axolotlbiosciences.com, 2026-11-08
Made for you already
Product claims in your published words only.
The channels we'd turn on
Your website
Pages that answer search and AI questions about bioinks for neural tissue.
Video and social
Full-length and vertical video, posts and carousels on LinkedIn, Instagram and YouTube.
Newsletters and events
To the lists you build, and before, at and after the conferences your buyers attend.
Sales
How we run a deal, shown on ours
Your team gets the same system we use with you: each account, each opportunity and each meeting planned on Miller Heiman's method, with content made for every meeting. Here's how it looks on our work together, in the open.
Three plans, one deal
The account plan
Everything known about a company: what it makes, who buys, what's moving in its market.
The opportunity plan
One deal: where it stands, who's involved, what has to be true to move it forward.
The meeting plan
Every call: what we want to learn, what we'll show, and the step we'd like to agree.
Who decides, as we understand it so far
Approves the spend
Your CEO
Sets the goal and signs off on the investment.
Judges the fit
Your CTO
Checks that the system fits how Axolotl works.
Uses it every day
To learn on call 2
The people who'd run outreach and content.
Guides us along the way
To learn on call 2
Someone who helps us get it right for your team.
Tell us where we have it wrong.
Our first call, planned this way
What we set out to do: learn how labs find TissuePrint today and who chooses the ink, show how we'd map your market, and agree a second call to walk this page together.
What we showed: our method, the research we ran on your market, and the samples on the Marketing tab.
Where we are: after call 1. Next: a second call, then a proposal sized to what you need.
The scope we're working toward
| Question | Status |
|---|---|
| What are you trying to accomplish in three months, and after? | opened on call 1 |
| How often does your team want to meet, and who's in the room? | opened on call 1 |
| Who on your side builds along? | opened on call 1 |
| What must it connect to: your web shop, a CRM, your cloud? | opened on call 1 |
| Which add-ons, if any: outbound, marketing, sales? | call 2 |
| Which market sources matter most to you? | call 2 |
The answers set the size of the Foundation and of any add-on. The price comes in the proposal.
For your own sales
- Your pipeline brought in, with each opportunity's plan beside it.
- Targets and messaging for each person who sells.
- A page and a short video for every meeting, like this one.
The BioCreative Academy
We build along with you
Everyone is at a different point, and the gap is widening. We meet each person where they are and close it with them, so your team owns what we build.
Every model release widens the gap
The general population
Little direct contact with AI yet.
Casual users
A chatbot, a search box or a writing aid.
Frontier users
Building with it in code and math, where weeks of work become one prompt.
Inside the frontier labs
A few thousand people with access to frontier systems.
From chat to a full operating system
Two GitHub repositories to start with
Level 1
The Academy Starter
Your own AI working system, the way BioCreative builds ours. Claude walks you through it one lesson at a time, and every lesson ends with a check.
Get the Academy StarterLevel 2
The LifeSci Lens Starter
Your context applied to real life-sciences data you own: an interface on your data, with the LLM applying your rules to every record.
Get the LifeSci Lens StarterFree for your whole team. In every engagement, we keep building with you, layer by layer.